VK

Vamsi Kiran Kosaraju

Active Director Director DIN 11283007
DIN 11283007 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Vamsi Kiran Kosaraju

Data last updated:

Vamsi Kiran Kosaraju is a Director at Meishi Pharma Services Private Limited (since 2025). The company operates in Pharma. Meishi Pharma Services Private Limited reported revenue of ₹20.29 Cr (FY 2025).

DIN 11283007
Primary Designation Director
Industry Pharma
First Appointment 09 Sep 2025
Oldest Company Age 4 yrs
Largest company Meishi Pharma Services Private Limited · ₹20.29 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Sep 20252022₹20.29 Cr (FY 2025)Active

Board colleagues of Vamsi Kiran Kosaraju

Directorship timeline

Open interactive timeline →
Meishi Pharma Services Private Limited
Premium access

Shareholding and investment profile for Vamsi Kiran Kosaraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vamsi Kiran Kosaraju

Vamsi Kiran Kosaraju currently holds 1 directorship: Meishi Pharma Services Private Limited (Director, since 09 Sep 2025, revenue ₹20.29 Cr (FY 2025)).

Vamsi Kiran Kosaraju was first appointed on 09 Sep 2025 as Director at Meishi Pharma Services Private Limited.

The current boards of Vamsi Kiran Kosaraju's companies include Ee Ling Chan (Meishi Pharma Services Private Limited), Mohit Suhas Patwardhan (Meishi Pharma Services Private Limited), Petar Vazharov (Meishi Pharma Services Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available